Ali Almheiri

Ali Almheiri

Auto-generated profile, based on publicly available information

Ali Almheiri

College of Medicine, University of Sharjah, Sharjah, United Arab Emirates

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2024 in Cardiac Failure Review
Verified
Journal Article
Open access
PDF file
MAMoza A Alzaabi
Moza A Alzaabi
AAAmin Abdelsalam
Amin Abdelsalam
MAMajid Alhammadi
Majid Alhammadi
HHHasan Bani Hani
Hasan Bani Hani
AAAli Almheiri
Ali Almheiri
Khaled Yahya Al ZamanKhaled Yahya Al Zaman
Khaled Yahya Al Zaman
There is a high prevalence of heart failure (HF) worldwide, which has significant consequences for healthcare costs, patient death and quality of life. Therefore, there has been much focus on finding and using biomarkers for early diagnosis, prognostication and therapy of HF. This overview of the research presents a thorough examination of the current state of HF biomarkers and their many uses. Their function in diagnosing HF, gauging its severity and monitoring its response to therapy are all discussed. Particularly promising in HF diagnosis and risk stratification are the cardiac-specific biomarkers, B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide. Markers of oxidative stress, extracellular matrix, renal function, inflammation and cardiac peptides have shown promise in evaluating HF severity and prognosis. MicroRNAs and insulin-like growth factor are two emerging biomarkers that have shown potential in helping with HF diagnosis and prognosis.